CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.93
-2.11 (-4.22%)
Nov 10, 2026, 10:28 AM EST - Market open

CRISPR Therapeutics AG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
12.6710.181.460.860.890.890.8735.690.60.520.5201.21-701000.010.090.160.9412.9
Revenue Growth
1325.08%1041.37%68.55%-97.58%47.67%72.53%71.63%-82.26%--99.26%-99.50%3353333.33%-44203.80%10538.30%-99.95%-88.59%-99.98%74.40%3386.22%
Gross Profit
-100.5-97.24-113.07-136.37-115.13-114.16-129.13-46.46-92.71-131.78-122.6386.06-114.12-76.19-42.13-110.37-155.39-156.99-147.95-122.02
Operating Income
-118.37-114.8-130.25-154.76-132.06-133.07-148.42-64.59-110.13-151.26-140.5969.58-132.41-95.22-64.49-131.54-182.39-183.26-175.97-145.7
Net Income
-111.44-91.15-122.93-130.61-106.44-208.55-136-37.31-85.94-126.41-116.5989.35-112.15-77.74-53.07-110.58-174.55-185.83-179.22-141.25
Earnings Per Share
-1.15-0.94-1.28-1.37-1.17-2.40-1.58-0.44-1.01-1.49-1.431.09-1.41-0.98-0.67-1.41-2.24-2.40-2.32-1.84
EPS Growth
--------------------

Revenue by Segment

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Collaboration
12.32101----35---200
Grant
0.350.180.460.860.890.890.870.690.60.520.51.21
Revenue (Total)
12.6710.181.460.860.890.890.8735.690.60.520.5201.21

Cash & Debt

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
2,2772,3642,4421,9761,9441,7211,8551,9041,9362,0132,1081,6961,7401,7731,8891,8681,9732,0742,2212,379
Total Debt
779.83783.75787.64206.75211.02215.45219.36223.69227.55231.3234.93238.63241.59245.18240.27244.02242.16242.43238.98225.03
Net Cash (Debt)
1,4971,5811,6541,7691,7331,5061,6361,6801,7081,7821,8731,4571,4981,5281,6491,6241,7311,8311,9822,154
Net Cash Growth
-13.64%4.97%1.11%5.29%1.46%-15.48%-12.67%15.31%14.01%16.61%13.58%-10.30%-13.44%-16.57%-16.80%-24.59%-23.81%-23.64%13.61%32.24%
Net Cash Per Share
15.4716.3817.2218.5718.9817.2919.0419.6620.0420.9822.9017.9218.8719.3220.9620.7422.1923.6325.7128.10

Cash Flow & CapEx

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-89.68-83.5-108.9-92.55-84.63-113.88-53.95-50.03-106.91-95.58109.75-96.07-39.86-133.258.8-113.33-105.22-141.96-135.24-86.04
Capital Expenditures
-0.41-0.65-0.5-0.52-0.07-0.12-0.21-0.25-0.22-0.71-0.72-0.74-2.12-3.56-3.06-6.19-6.02-9.63-15.35-9.18
Free Cash Flow
-90.1-84.15-109.4-93.07-84.71-114-54.15-50.29-107.13-96.29109.03-96.81-41.97-136.85.74-119.52-111.24-151.59-150.59-95.22
Free Cash Flow Growth
----------1799.49%---------

Margins

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
--------130.18%---42.77%--108.84%-42.13%-----
Operating Margin
-934.33%-1127.55%-8933.33%-17912.50%-14854.78%-14918.27%-17158.84%-180.96%-18294.02%-29257.25%-27894.25%34.58%--136.03%-64.49%-2192350.00%-194029.79%-115987.34%-18720.43%-1129.53%
Pretax Margin
-879.02%-885.91%-8373.94%-15046.18%-11903.49%-23235.09%-15593.87%-102.58%-14130.56%-24201.35%-22989.48%44.52%--109.74%-51.74%-2000850.00%-186302.13%-113744.30%-18681.81%-1112.50%
Profit Margin
-879.60%-895.33%-8431.48%-15117.24%-11973.12%-23379.93%-15722.08%-104.54%-14276.08%-24450.29%-23133.13%44.41%--111.06%-53.06%-1842916.67%-185690.43%-117616.46%-19065.64%-1095.03%
FCF Margin
-711.17%-826.50%-7503.50%-10771.99%-9528.46%-12779.93%-6260.46%-140.89%-17796.01%-18624.57%21633.13%-48.12%--195.43%5.74%-1991983.33%-118335.11%-95940.51%-16020.11%-738.20%

Valuation

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PS Ratio
212.50401.091112.851423.80153.76112.7677.4890.0320.5022.6820.1413.40-27.5135.482656.64361.78317.595.296.34